Paper76447
Silent corticotroph cell adenoma with lysosomal accumulation and crinophagy. A distinct clinicopathologic entity.
Kovacs K and 4 others. Am J Med, 1978. Cited by 122 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Silent corticotroph cell adenoma with lysosomal accumulation and crinophagy. A distinct clinicopathologic entity. Papers, record 76447. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/76447
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Silent corticotroph cell adenoma with lysosomal accumulation and crinophagy. A distinct clinicopathologic entity.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenoma, Basophil | Major topic |
| Lysosomes | Major topic |
| Pituitary Neoplasms | Major topic |
| Adrenocorticotropic Hormone | |
| Adult | |
| Cosyntropin | |
| Cytoplasm | |
| Cytoplasmic Granules | |
| Humans | |
| Hydrocortisone | |
| Hypothalamo-Hypophyseal System | |
| Male | |
| Pituitary-Adrenal System | |
| Staining and Labeling |
Source PubMed
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 122 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,066,842 | The diverging role of O-GlcNAc transferase in corticotroph and somatotroph adenomas. | Pituitary | 2024 | https://conductscience.org/library/papers/39066842 | PubMed |
| 37,212,418 | A silent corticotroph adenoma: making the case for a pars intermedia origin. Illustrative case. | J Neurosurg Case Lessons | 2023 | https://conductscience.org/library/papers/37212418 | PubMed |
| 35,837,315 | Architects of Pituitary Tumour Growth. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35837315 | PubMed |
| 35,634,489 | Quantitative Ubiquitinomics Revealed Abnormal Ubiquitinated ATP7A Involved in Down-Regulation of ACTH in Silent Corticotroph Adenomas. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35634489 | PubMed |
| 34,885,244 | An Update on Silent Corticotroph Adenomas: Diagnosis, Mechanisms, Clinical Features, and Management. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34885244 | PubMed |
| 34,220,707 | Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34220707 | PubMed |
| 33,986,726 | Recent Understanding and Future Directions of Recurrent Corticotroph Tumors. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/33986726 | PubMed |
| 33,821,422 | Autophagy in normal pituitary and pituitary tumor cells and its potential role in the actions of somatostatin receptor ligands in acromegaly. | Rev Endocr Metab Disord | 2021 | https://conductscience.org/library/papers/33821422 | PubMed |
| 33,584,540 | Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/33584540 | PubMed |
| 33,476,035 | The silent variants of pituitary tumors: demographic, radiological and molecular characteristics. | J Endocrinol Invest | 2021 | https://conductscience.org/library/papers/33476035 | PubMed |
| 33,071,973 | Clinical, Laboratory, and Treatment Profiles of Silent Corticotroph Adenomas That Have Transformed to the Functional Type: A Case Series With a Literature Review. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/33071973 | PubMed |
| 32,370,421 | A composite somatotroph-corticotroph pituitary adenoma. | Endocr Pathol | 1994 | https://conductscience.org/library/papers/32370421 | PubMed |
| 32,357,637 | Silent mixed growth hormone cell-prolactin cell pituitary adenoma. | Endocr Pathol | 1991 | https://conductscience.org/library/papers/32357637 | PubMed |
| 32,138,413 | Corticotroph (Basophil) invasion of the pars nervosa in the human pituitary: Localization of proopiomelanocortin peptides, galanin and peptidylglycine α-amidating monooxygenase-like immunoreactivities. | Endocr Pathol | 1993 | https://conductscience.org/library/papers/32138413 | PubMed |
| 31,671,410 | Postoperative expression of Cushing disease in a young male: metamorphosis of silent corticotroph adenoma? | Endocrinol Diabetes Metab Case Rep | 2019 | https://conductscience.org/library/papers/31671410 | PubMed |
| 30,228,864 | Recent advances in understanding corticotroph pituitary tumor initiation and progression. | F1000Res | 2018 | https://conductscience.org/library/papers/30228864 | PubMed |
| 30,020,466 | Clinical and Pathological Aspects of Silent Pituitary Adenomas. | J Clin Endocrinol Metab | 2019 | https://conductscience.org/library/papers/30020466 | PubMed |
| 29,434,339 | Epidemiology and biomarker profile of pituitary adenohypophysial tumors. | Mod Pathol | 2018 | https://conductscience.org/library/papers/29434339 | PubMed |
| 29,290,044 | Aggressive somatotrophinomas lacking clinical symptoms: neurosurgical management. | Neurosurg Rev | 2018 | https://conductscience.org/library/papers/29290044 | PubMed |
| 29,032,459 | Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review. | Pituitary | 2018 | https://conductscience.org/library/papers/29032459 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/76447
GET https://conductscience.org/api/papers/v1/76447/cited_by?page=2